LEADER 02219nam  2200589   450 
001 9910790753703321
005 20230422051046.0
010   $a0-8179-9908-6
035   $a(CKB)2550000001166908
035   $a(EBL)1572175
035   $a(SSID)ssj0001083814
035   $a(PQKBManifestationID)12471111
035   $a(PQKBTitleCode)TC0001083814
035   $a(PQKBWorkID)11021884
035   $a(PQKB)11537104
035   $a(MiAaPQ)EBC1572175
035   $a(Au-PeEL)EBL1572175
035   $a(CaPaEBR)ebr10816486
035   $a(CaONFJC)MIL548297
035   $a(OCoLC)864747296
035   $a(EXLCZ)992550000001166908
100   $a20000424d2000      uy|            0
101 0 $aeng
135   $aurcnu||||||||
181   $ctxt
182   $cc
183   $acr
200 10$aTo America's health $ea proposal to reform the Food and Drug Administration /$fHenry I. Miller
210  1$aStanford, California :$cHoover Institution Press,$d2000.
215   $a1 online resource (128 p.)
225  0$aHoover Institution Press publication ;$v482
300   $aDescription based upon print version of record.
311   $a0-8179-9902-7 
311   $a1-306-17046-X 
320   $aIncludes bibliographical references and index.
327   $apart I. The need for fundamental food and drug administration reform -- part II. A model for reform of the food and drug administration.
330   $aA government monopoly over drug regulation is not sacrosanct. This hard-hitting book describes the current regulation of drugs by the FDA and proposes a model for fundamental, yet workable, reform including an innovative proposal for drug testing and certification review.
606   $aPharmaceutical policy$zUnited States
606   $aDrugs$xLaw and legislation$zUnited States
606   $aPharmaceutical industry$zUnited States
615  0$aPharmaceutical policy
615  0$aDrugs$xLaw and legislation
615  0$aPharmaceutical industry
676   $a353.9/98/0973
700   $aMiller$b Henry I$01582049
801  0$bMiAaPQ
801  1$bMiAaPQ
801  2$bMiAaPQ
906   $aBOOK
912   $a9910790753703321
996   $aTo America's health$93864028
997   $aUNINA